During the past decade, West Virginia University Heart and Vascular Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Virginia University Heart and Vascular Institute" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Ionis Pharmaceuticals, Inc." with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Biostable Science & Engineering" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Virginia University Heart and Vascular Institute" #1 collaborator was "Akcea Therapeutics" with 1 trials as a collaborator and "BTG International Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "West Virginia University Heart and Vascular Institute" are "Acute Kidney Injury (AKI)" (1 trials), "Aortic Aneurysm" (1 trials), "Aortic Valve Insufficiency" (1 trials), "Aortic Valve Stenosis" (1 trials) and "Circadian Rhythm Disorders" (1 trials). Many other conditions were trialed in "West Virginia University Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "West Virginia University Heart and Vascular Institute" are "Drug" (6 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Olezarsen" (2 trials), "ASP1128" (1 trials), "Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin" (1 trials) and "Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline" (1 trials). Other intervention names were less common.

The vast majority of trials in "West Virginia University Heart and Vascular Institute" are 10 trials for "All" genders.

Currently, there are NaN active trials in "West Virginia University Heart and Vascular Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 2 completed trials in West Virginia University Heart and Vascular Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in West Virginia University Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".